Study identifier:D1710C00013
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A randomised, placebo-controlled, single-blind, single centre Phase I study to Assess the Safety, Tolerability and Pharmacokinetics of ascending Single Oral Dose of AZD5672 in Healthy Japanese Male Volunteers
Rheumatoid Arthritis
Phase 1
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|